Drug
Bibr 1048 MS Low
Bibr 1048 MS Low: highest development phase Phase 1, developed by Boehringer Ingelheim. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Boehringer Ingelheim
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIBR 1048 MS low NCT02170831 | Phase 1 | Healthy |
Latest
No recent events.
Follow Bibr 1048 MS Low on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.